Samco Small Cap Fund
Direct · GrowthAI Summary
Samco Small Cap Fund has outperformed the NIFTY SmallCap 250 benchmark across all measured periods, with a 1Y fund CAGR of 26.79% versus 9.02% for the benchmark and a 3Y CAGR of 8.23% versus 2.92%. Alpha is strongest at 18.12% over 1Y but narrows to 4.82% over 3Y and 2.47% over 5Y, indicating the outperformance edge diminishes over longer horizons. SIP XIRR data is not available, so a like-for-like comparison with category average SIP XIRR (17.78% over 1Y, 20.24% over 3Y) cannot be made.
The fund shows a low maximum drawdown of -0.12% with a 76-day duration and a quick 25-day recovery, with only one drawdown event exceeding 10%, suggesting contained downside so far. Beta of 0.8627 indicates the fund moves less than the benchmark, and its downside capture of 79.36% versus upside capture of 97.69% reflects a favorable asymmetry — it loses less in down markets while participating nearly fully in up markets. This combination supports a solid risk-adjusted return profile relative to the benchmark.
The top 10 holdings account for roughly 28.6% of NAV across 70 total stocks, indicating a well-diversified portfolio with no single stock exceeding 4.65% (Karur Vysya Bank). Sector exposure is balanced, led by Capital Markets (8.3%), Banks (8.3%), and Pharmaceuticals (8.1%), with meaningful allocations to Auto Components (6.5%) and Industrial Products (5.8%). The portfolio spans financials, healthcare, IT services, and industrials, reducing single-sector concentration risk.
The fund's consistent benchmark outperformance across 1Y through 15Y windows, with positive alpha at every horizon, suggests durable stock selection rather than a one-period fluke. However, since the fund's SIP XIRR is unavailable, direct comparison with category average SIP XIRR figures is not possible, and investors should note that lump-sum CAGRs of 8.23% (3Y) and 4.86% (5Y) reflect weak broader small-cap market conditions during those windows. Its low downside capture and sub-1 beta position it as a relatively defensive small-cap offering among peers.
This fund suits investors with high risk tolerance seeking small-cap exposure with a defensive tilt, given its below-benchmark beta and strong downside capture characteristics. A time horizon of at least 5-7 years is recommended, as small-cap returns are volatile over shorter periods, as evidenced by the modest 3Y and 5Y CAGRs. It is appropriate as a satellite allocation within a diversified portfolio rather than a core holding.
- Outperformed the NIFTY SmallCap 250 benchmark across all time horizons, with 1Y alpha of 18.12% and positive alpha even over 15Y
- Favorable capture asymmetry: downside capture of 79.36% versus upside capture of 97.69%, meaning it falls less than the benchmark in weak markets
- Well-diversified portfolio of 70 stocks with top holding at only 4.65% of NAV and balanced sector exposure
- Alpha narrows significantly over longer horizons, from 18.12% at 1Y to just 2.47% at 5Y, suggesting the outperformance edge may be period-specific
- SIP XIRR data is unavailable, preventing direct comparison with category average SIP XIRR (20.24% over 3Y) and limiting full performance evaluation
Generated on 20-10-2026, 3:08 AM. Verify before investing.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
Not enough data to compute SIP returns.
Not enough data to compute rolling returns.
Compared against NIFTY SMALLCAP 250
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +18.12 | 0.86 | 97.7% | 79.4% | 26.8% | 9.0% |
| 3 Years | +4.82 | 0.86 | 97.7% | 79.4% | 8.2% | 2.9% |
| 5 Years | +2.47 | 0.86 | 97.7% | 79.4% | 4.9% | 1.7% |
| 7 Years | +1.49 | 0.86 | 97.7% | 79.4% | 3.5% | 1.2% |
| 10 Years | +0.76 | 0.86 | 97.7% | 79.4% | 2.4% | 0.9% |
| 12 Years | +0.49 | 0.86 | 97.7% | 79.4% | 2.0% | 0.7% |
| 15 Years | +0.20 | 0.86 | 97.7% | 79.4% | 1.6% | 0.6% |
| # | Stock | % of NAV |
|---|---|---|
| 1 | Karur Vysya Bank Limited | 4.65% |
| 2 | Affle 3i Limited | 3.30% |
| 3 | JB Chemicals & Pharmaceuticals Limited | 3.22% |
| 4 | Aditya Birla Sun Life AMC Limited | 3.10% |
| 5 | Can Fin Homes Limited | 2.84% |
| 6 | Timken India Limited | 2.48% |
| 7 | Pfizer Limited | 2.46% |
| 8 | Engineers India Limited | 2.23% |
| 9 | LT Foods Limited | 2.21% |
| 10 | UTI Asset Management Company Limited | 2.15% |